| Device |
filler, recombinant human bone morphogenetic protein, collagen scaffold, osteoinduction - hde |
| Definition |
Device type: Filler, recombinant human bone morphogenetic protein, collagen scaffold, osteoinduction, revision spine surgery, autograft not available or feasible - replacement for autograft bone in patients where autograft is unavailable or not feasible to harvest. Not feasible to harvest is intended to means presence of a condition where normal bone metabolism would be expected to prevent healing, e.G., smokers and diabetics. Revision spine surgery to treat pseudarthrosis. |
| Physical State |
none |
| Technical Method |
Product provides signal for cell differentiation and scaffold for new bone growth |
| Target Area |
spine |
| Review Panel |
Orthopedic |
| Product Code | OJZ |
| Premarket Review |
Office of Orthopedic Devices
(OHT6)
Restorative, Repair and Trauma Devices
(DHT6C)
|
| Submission Type |
HDE - Humanitarian Device Exemption
|
| Device Class |
HDE
|
| Total Product Life Cycle (TPLC) |
TPLC Product Code Report
|
| GMP Exempt? |
No
|
Summary Malfunction Reporting |
Eligible |
| Implanted Device? |
Yes
|
| Life-Sustain/Support Device? |
No
|
| Third Party Review |
Not Third Party Eligible |
|
|